The pharma major's consolidated net profit jumped 46.55% to Rs 510 crore on 22.47% increase in revenue from operations to Rs 2,338 crore in Q2 FY25 over Q2 FY24.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.